Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1093

1.

The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.

Karunaratne K, Stevens P, Irving J, Hobbs H, Kilbride H, Kingston R, Farmer C.

Nephrol Dial Transplant. 2013 Aug;28(8):2107-16. doi: 10.1093/ndt/gft093. Epub 2013 May 7.

PMID:
23658247
2.

Treatment of hypertension in chronic kidney disease.

Toto RD.

Semin Nephrol. 2005 Nov;25(6):435-9. Review.

PMID:
16298269
3.

Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.

BMC Fam Pract. 2013 Jun 24;14:88. doi: 10.1186/1471-2296-14-88.

4.

Management of hypertension in patients with CKD: differences between primary and tertiary care settings.

Minutolo R, De Nicola L, Zamboli P, Chiodini P, Signoriello G, Toderico C, Arfè G, Boschi G, Brancati C, Iaccarino P, Conte G.

Am J Kidney Dis. 2005 Jul;46(1):18-25.

PMID:
15983953
5.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
6.

Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.

Omae K, Ogawa T, Nitta K.

Heart Vessels. 2010 May;25(3):203-8. doi: 10.1007/s00380-009-1188-4. Epub 2010 May 29.

PMID:
20512447
7.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

Can J Cardiol. 2009 May;25(5):287-98. Review.

8.

Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.

Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP.

J Hypertens. 2005 Nov;23(11):2093-100.

PMID:
16208153
9.

Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.

Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.

Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10.

PMID:
19073656
10.

Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan.

Yamashita T, Yoshida T, Ogawa T, Tsuchiya K, Nitta K.

Clin Exp Nephrol. 2011 Dec;15(6):831-40. doi: 10.1007/s10157-011-0501-6. Epub 2011 Jul 30.

PMID:
21800234
11.

Hypertension control and antihypertensive therapy in patients with chronic kidney disease.

Unni S, White K, Goodman M, Ye X, Mavros P, Bash LD, Brixner D.

Am J Hypertens. 2015 Jun;28(6):814-22. doi: 10.1093/ajh/hpu215. Epub 2014 Nov 24.

PMID:
25421796
12.

Hypertension, antihypertensive agents and outcomes following renal transplantation.

Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RS, Geddes CC, Jardine AG.

Clin Transplant. 2005 Apr;19(2):181-92.

PMID:
15740553
13.

A retrospective review of diabetic nephropathy patients during referral to the sub-urban nephrology clinic.

Menon R, Mohd Noor FS, Draman CR, Seman MR, Ghani AS.

Saudi J Kidney Dis Transpl. 2012 Sep;23(5):1109-14. doi: 10.4103/1319-2442.100972.

14.

Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.

Chen YR, Yang Y, Wang SC, Chiu PF, Chou WY, Lin CY, Chang JM, Chen TW, Ferng SH, Lin CL.

Nephrol Dial Transplant. 2013 Mar;28(3):671-82. doi: 10.1093/ndt/gfs469. Epub 2012 Dec 6.

PMID:
23223224
15.

Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.

Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, Wada T.

Hypertens Res. 2009 Dec;32(12):1123-9. doi: 10.1038/hr.2009.165. Epub 2009 Oct 9.

PMID:
19816503
16.

Progression to hypertension in non-hypertensive children following renal transplantation.

Sinha MD, Gilg JA, Kerecuk L, Reid CJ; British Association for Paediatric Nephrology.

Nephrol Dial Transplant. 2012 Jul;27(7):2990-6. doi: 10.1093/ndt/gfr784. Epub 2012 Jan 28.

PMID:
22287656
17.

CKD awareness and blood pressure control in the primary care hypertensive population.

Ravera M, Noberasco G, Weiss U, Re M, Gallina AM, Filippi A, Cannavò R, Ravera G, Cricelli C, Deferrari G.

Am J Kidney Dis. 2011 Jan;57(1):71-7. doi: 10.1053/j.ajkd.2010.08.022. Epub 2010 Nov 17.

PMID:
21087817
18.

Prevalence and management of chronic kidney disease in primary care patients in the UK.

Jameson K, Jick S, Hagberg KW, Ambegaonkar B, Giles A, O'Donoghue D.

Int J Clin Pract. 2014 Sep;68(9):1110-21. doi: 10.1111/ijcp.12454. Epub 2014 May 23.

PMID:
24852335
19.

Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study).

Razavian M, Heeley EL, Perkovic V, Zoungas S, Weekes A, Patel AA, Anderson CS, Chalmers JP, Cass A.

Nephrol Dial Transplant. 2012 Apr;27(4):1396-402. doi: 10.1093/ndt/gfr599. Epub 2011 Nov 2.

PMID:
22053091
20.

Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.

Pisoni R, Acelajado MC, Cartmill FR, Dudenbostel T, Dell'Italia LJ, Cofield SS, Oparil S, Calhoun DA.

J Hum Hypertens. 2012 Aug;26(8):502-6. doi: 10.1038/jhh.2011.60. Epub 2011 Jun 16.

PMID:
21677673

Supplemental Content

Support Center